BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 12111854)

  • 1. Acute administration of Ginkgo biloba extract (EGb 761) affords neuroprotection against permanent and transient focal cerebral ischemia in Sprague-Dawley rats.
    Lee EJ; Chen HY; Wu TS; Chen TY; Ayoub IA; Maynard KI
    J Neurosci Res; 2002 Jun; 68(5):636-45. PubMed ID: 12111854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained neuroprotection and facilitation of behavioral recovery by the Ginkgo biloba extract, EGb 761, after transient forebrain ischemia in rats.
    Paganelli RA; Benetoli A; Milani H
    Behav Brain Res; 2006 Nov; 174(1):70-7. PubMed ID: 16934342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of proteins differentially expressed in cerebral cortexes of Ginkgo biloba extract (EGb761)-treated rats in a middle cerebral artery occlusion model--a proteomics approach.
    Koh PO
    Am J Chin Med; 2011; 39(2):315-24. PubMed ID: 21476208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gingko biloba extract (EGb 761) prevents increase of Bad-Bcl-XL interaction following cerebral ischemia.
    Koh PO
    Am J Chin Med; 2009; 37(5):867-76. PubMed ID: 19885947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
    Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
    J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ginkgo biloba extract, EGb 761, fails to reduce brain infarct size in rats after transient, middle cerebral artery occlusion in conditions of unprevented, ischemia-induced fever.
    de Lima KC; Schilichting CL; Junior LA; da Silva FM; Benetoli A; Milani H
    Phytother Res; 2006 Jun; 20(6):438-43. PubMed ID: 16619358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginkgo biloba extract neuroprotective action is dependent on heme oxygenase 1 in ischemic reperfusion brain injury.
    Saleem S; Zhuang H; Biswal S; Christen Y; Doré S
    Stroke; 2008 Dec; 39(12):3389-96. PubMed ID: 18845796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed treatment with melatonin enhances electrophysiological recovery following transient focal cerebral ischemia in rats.
    Lee EJ; Wu TS; Lee MY; Chen TY; Tsai YY; Chuang JI; Chang GL
    J Pineal Res; 2004 Jan; 36(1):33-42. PubMed ID: 14675128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gingko biloba Extract (EGb 761) prevents ischemic brain injury by activation of the Akt signaling pathway.
    Cho JH; Sung JH; Cho EH; Won CK; Lee HJ; Kim MO; Koh PO
    Am J Chin Med; 2009; 37(3):547-55. PubMed ID: 19606514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gingko biloba extract (EGb 761) prevents cerebral ischemia-induced p70S6 kinase and S6 phosphorylation.
    Koh PO
    Am J Chin Med; 2010; 38(4):727-34. PubMed ID: 20626058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of antioxidant therapies in transient focal ischemia in mice.
    Clark WM; Rinker LG; Lessov NS; Lowery SL; Cipolla MJ
    Stroke; 2001 Apr; 32(4):1000-4. PubMed ID: 11283403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of isradipine, an L-type calcium channel blocker on permanent and transient focal cerebral ischemia in spontaneously hypertensive rats.
    Campbell CA; Mackay KB; Patel S; King PD; Stretton JL; Hadingham SJ; Hamilton TC
    Exp Neurol; 1997 Nov; 148(1):45-50. PubMed ID: 9398449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model.
    Pei Z; Pang SF; Cheung RT
    Stroke; 2003 Mar; 34(3):770-5. PubMed ID: 12624306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat.
    Sun HS; Doucette TA; Liu Y; Fang Y; Teves L; Aarts M; Ryan CL; Bernard PB; Lau A; Forder JP; Salter MW; Wang YT; Tasker RA; Tymianski M
    Stroke; 2008 Sep; 39(9):2544-53. PubMed ID: 18617669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Ginkgo biloba extract-761 on motor functions in permanent middle cerebral artery occlusion rats.
    Zeng GR; Zhou SD; Shao YJ; Zhang MH; Dong LM; Lv JW; Zhang HX; Tang YH; Jiang DJ; Liu XM
    Phytomedicine; 2018 Sep; 48():94-103. PubMed ID: 30195885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed treatment with magnesium: reduction of brain infarction and improvement of electrophysiological recovery following transient focal cerebral ischemia in rats.
    Lee EJ; Lee MY; Chang GL; Chen LH; Hu YL; Chen TY; Wu TS
    J Neurosurg; 2005 Jun; 102(6):1085-93. PubMed ID: 16028768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of Ginkgo biloba extract (EGb 761) promotes neurovascular restoration and axonal remodeling after embolic stroke in rat using magnetic resonance imaging and histopathological analysis.
    Li MZ; Zhang Y; Zou HY; Ouyang JY; Zhan Y; Yang L; Cheng BC; Wang L; Zhang QX; Lei JF; Zhao YY; Zhao H
    Biomed Pharmacother; 2018 Jul; 103():989-1001. PubMed ID: 29710516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke.
    Khan M; Sekhon B; Jatana M; Giri S; Gilg AG; Sekhon C; Singh I; Singh AK
    J Neurosci Res; 2004 May; 76(4):519-27. PubMed ID: 15114624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FK506 ameliorates oxidative damage and protects rat brain following transient focal cerebral ischemia.
    Nito C; Ueda M; Inaba T; Katsura K; Katayama Y
    Neurol Res; 2011 Oct; 33(8):881-9. PubMed ID: 22004713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window.
    Sydserff SG; Borelli AR; Green AR; Cross AJ
    Br J Pharmacol; 2002 Jan; 135(1):103-12. PubMed ID: 11786485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.